ESCRS - PP24.10 - Microcpc Treatment For Glaucoma Latino Patients : Efficacy And Safety On 6-Months Follow Up

Microcpc Treatment For Glaucoma Latino Patients : Efficacy And Safety On 6-Months Follow Up

Published 2025 - 43rd Congress of the ESCRS

Reference: PP24.10 | Type: Poster | DOI: 10.82333/z6j9-9w03

Authors: Luis Miguel Oviedo Plathi* 1 , Jean Morales 2 , Michele Petitto 3 , Nelly Rosillo 4 , Jose Galue 5 , Humberto Ramirez 6 , Raul Rabinovich 7

1Glaucoma,Hospital Universitario de Maracaibo,Maracaibo,Venezuela, Bolivarian Republic Of;Glaucoma,IDEO,Maracaibo,Venezuela, Bolivarian Republic Of;Glaucoma,Clinica de Ojos,Maracaibo,Venezuela, Bolivarian Republic Of, 2Anterior Segment & Cornea,Hospital Universitario de Maracaibo,Maracaibo,Venezuela, Bolivarian Republic Of;Anterior Segment & Cornea,IDEO,Maracaibo,Venezuela, Bolivarian Republic Of, 3Glaucoma,Clinica de Ojos,Maracaibo,Venezuela, Bolivarian Republic Of, 4Glaucoma,IDEO,Maracaibo,Venezuela, Bolivarian Republic Of, 5Anterior Segment & Cornea,Hospital Universitario de Maracaibo,Maracaibo,Venezuela, Bolivarian Republic Of;Anterior Segment & Cornea,Clinica de Ojos,Maracaibo,Venezuela, Bolivarian Republic Of, 6Glaucoma,Hospital Universitario de Maracaibo,Maracaibo,Venezuela, Bolivarian Republic Of, 7Anterior Segment & Cornea,Hospital Universitario de Maracaibo,Maracaibo,Venezuela, Bolivarian Republic Of

Purpose

To evaluate the safety and effectiveness of µCPC in patients with different types of uncontrolled glaucoma in latin american patients.
 

Setting

University Hospital of Maracaibo, Maracaibo – Zulia.

Methods

Prospective, longitudinal, non-experimental and field study, with a sample of 60 patients with refractory glaucoma, submitted to transscleral μCPC therapy, the parameters evaluated were preoperative intraocular pressure, day 1, week 1, month 1, month 3 and month 6; the presence of pain prior to surgery was evaluated and at month 6, Medication use at baseline and 6 months after the procedure was also evaluated, as well as the number of complications present in each patient.

Results

The mean baseline IOP was 36.66 ± 13.10 mmHg, at 6 months they achieved a reduction in IOP of 53.19% of baseline, there were statistically significant reduction (p< 0.05). All Patients showed an effective reduction in pain compared to baseline (p< 0.05); Regarding the reduction in the use of drugs, the average of reduction was 3 drugs less compared to the baseline, all patients presented minor complications and rapid resolution.

Conclusions

μCPC technique used is effective for the control of IOP in refractory glaucoma and pain reduction, they were also found to be effective in reducing the number of drugs used, with an acceptable safety profile.